A citation-based method for searching scientific literature

Gonzalo Martínez-Alés, Tammy Jiang, Katherine M Keyes, Jaimie L Gradus. Annu Rev Public Health 2022
Times Cited: 5







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


County-Level Trends in Suicide Rates in the U.S., 2005-2015.
Lauren M Rossen, Holly Hedegaard, Diba Khan, Margaret Warner. Am J Prev Med 2018
42
40

Trends in Suicide Rates by Race and Ethnicity in the United States.
Rajeev Ramchand, Joshua A Gordon, Jane L Pearson. JAMA Netw Open 2021
28
40

Abnormal structural networks characterize major depressive disorder: a connectome analysis.
Mayuresh S Korgaonkar, Alex Fornito, Leanne M Williams, Stuart M Grieve. Biol Psychiatry 2014
222
20

More treatment but no less depression: The treatment-prevalence paradox.
Johan Ormel, Steven D Hollon, Ronald C Kessler, Pim Cuijpers, Scott M Monroe. Clin Psychol Rev 2022
11
20

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
583
20

Pharmacological approaches to the challenge of treatment-resistant depression.
Dawn F Ionescu, Jerrold F Rosenbaum, Jonathan E Alpert. Dialogues Clin Neurosci 2015
58
20

Changes in Prevalence of Mental Illness Among US Adults During Compared with Before the COVID-19 Pandemic.
Ronald C Kessler, Wai Tat Chiu, Irving H Hwang, Victor Puac-Polanco, Nancy A Sampson, Hannah N Ziobrowski, Alan M Zaslavsky. Psychiatr Clin North Am 2022
3
33

Serotonin syndrome.
Jacqueline Volpi-Abadie, Adam M Kaye, Alan David Kaye. Ochsner J 2013
140
20


A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics.
Neil K Savalia, Ling-Xiao Shao, Alex C Kwan. Trends Neurosci 2021
29
20

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.
Matthew W Johnson, Peter S Hendricks, Frederick S Barrett, Roland R Griffiths. Pharmacol Ther 2019
121
20


Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Alan K Davis, Frederick S Barrett, Darrick G May, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Patrick H Finan, Roland R Griffiths. JAMA Psychiatry 2021
216
20

Identification of Psychoplastogenic N,N-Dimethylaminoisotryptamine (isoDMT) Analogues through Structure-Activity Relationship Studies.
Lee E Dunlap, Arya Azinfar, Calvin Ly, Lindsay P Cameron, Jayashri Viswanathan, Robert J Tombari, Douglas Myers-Turnbull, Jack C Taylor, Ana Cristina Grodzki, Pamela J Lein,[...]. J Med Chem 2020
23
20



Aripiprazole for schizophrenia.
H G El-Sayeh, C Morganti. Cochrane Database Syst Rev 2006
61
20

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
John P O'Reardon, H Brent Solvason, Philip G Janicak, Shirlene Sampson, Keith E Isenberg, Ziad Nahas, William M McDonald, David Avery, Paul B Fitzgerald, Colleen Loo,[...]. Biol Psychiatry 2007
988
20

DARK Classics in Chemical Neuroscience: Psilocybin.
Haden A Geiger, Madeline G Wurst, R Nathan Daniels. ACS Chem Neurosci 2018
35
20


Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries.
Anthony F Jorm, Scott B Patten, Traolach S Brugha, Ramin Mojtabai. World Psychiatry 2017
207
20

Classics in chemical neuroscience: clozapine.
Cody J Wenthur, Craig W Lindsley. ACS Chem Neurosci 2013
70
20

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
20

Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
J Shawn Goodwin, Gaynor A Larson, Jarod Swant, Namita Sen, Jonathan A Javitch, Nancy R Zahniser, Louis J De Felice, Habibeh Khoshbouei. J Biol Chem 2009
138
20

Transient Stimulation with Psychoplastogens Is Sufficient to Initiate Neuronal Growth.
Calvin Ly, Alexandra C Greb, Maxemiliano V Vargas, Whitney C Duim, Ana Cristina G Grodzki, Pamela J Lein, David E Olson. ACS Pharmacol Transl Sci 2020
24
20

Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
Ezio Carboni, Anna R Carta, Elena Carboni, Antonello Novelli. Front Neurosci 2021
7
20


Psychedelics.
Benjamin Kelmendi, Alfred P Kaye, Christopher Pittenger, Alex C Kwan. Curr Biol 2022
3
33

Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.
Mark S George, Sarah H Lisanby, David Avery, William M McDonald, Valerie Durkalski, Martina Pavlicova, Berry Anderson, Ziad Nahas, Peter Bulow, Paul Zarkowski,[...]. Arch Gen Psychiatry 2010
601
20

[Therapeutic effect of psilocybin on convulsive neurosis].
J DELAY, P PICHOT, T LEMPERIERE, A M QUETIN. Ann Med Psychol (Paris) 1959
2
50

Antidepressant efficacy and side-effect burden: a quick guide for clinicians.
Daniel Santarsieri, Thomas L Schwartz. Drugs Context 2015
72
20

Depressive Rumination, the Default-Mode Network, and the Dark Matter of Clinical Neuroscience.
J Paul Hamilton, Madison Farmer, Phoebe Fogelman, Ian H Gotlib. Biol Psychiatry 2015
380
20

Transcranial magnetic stimulation (TMS) for geriatric depression.
Davide Cappon, Tim den Boer, Caleb Jordan, Wanting Yu, Eran Metzger, Alvaro Pascual-Leone. Ageing Res Rev 2022
7
20

Classics in Chemical Neuroscience: Chlorpromazine.
Debra Boyd-Kimball, Katelyn Gonczy, Benjamin Lewis, Thomas Mason, Nicole Siliko, Jacob Wolfe. ACS Chem Neurosci 2019
25
20

Increased global integration in the brain after psilocybin therapy for depression.
Richard E Daws, Christopher Timmermann, Bruna Giribaldi, James D Sexton, Matthew B Wall, David Erritzoe, Leor Roseman, David Nutt, Robin Carhart-Harris. Nat Med 2022
28
20

Animal models of serotonergic psychedelics.
James B Hanks, Javier González-Maeso. ACS Chem Neurosci 2013
85
20


Psychedelic-inspired drug discovery using an engineered biosensor.
Chunyang Dong, Calvin Ly, Lee E Dunlap, Maxemiliano V Vargas, Junqing Sun, In-Wook Hwang, Arya Azinfar, Won Chan Oh, William C Wetsel, David E Olson,[...]. Cell 2021
35
20

Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.
Martin L Williams, Diana Korevaar, Renee Harvey, Paul B Fitzgerald, Paul Liknaitzky, Sean O'Carroll, Prashanth Puspanathan, Margaret Ross, Nigel Strauss, James Bennett-Levy. Front Psychiatry 2021
3
33

Mechanism of Repetitive Transcranial Magnetic Stimulation for Depression.
Zhengwu Peng, Cuihong Zhou, Shanshan Xue, Jie Bai, Shoufen Yu, Xiaosa Li, Huaning Wang, Qingrong Tan. Shanghai Arch Psychiatry 2018
31
20


Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.
Ling-Xiao Shao, Clara Liao, Ian Gregg, Pasha A Davoudian, Neil K Savalia, Kristina Delagarza, Alex C Kwan. Neuron 2021
58
20

The influence of ketamine on drug discovery in depression.
Christoph Kraus, Daniel Wasserman, Ioline D Henter, Elia Acevedo-Diaz, Bashkim Kadriu, Carlos A Zarate. Drug Discov Today 2019
33
20

Mechanism of action of antidepressant medications.
J P Feighner. J Clin Psychiatry 1999
186
20

Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis.
Tianchen Wu, Xiaoqian Jia, Huifeng Shi, Jieqiong Niu, Xiaohan Yin, Jialei Xie, Xiaoli Wang. J Affect Disord 2021
360
20

Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Frederick S Barrett, Manoj K Doss, Nathan D Sepeda, James J Pekar, Roland R Griffiths. Sci Rep 2020
79
20

Prevalence and Associated Features of Anxiety Disorder Comorbidity in Bipolar Disorder: A Meta-Analysis and Meta-Regression Study.
Hale Yapici Eser, Anil S Kacar, Can M Kilciksiz, Merve Yalçinay-Inan, Dost Ongur. Front Psychiatry 2018
31
20

Potential Therapeutic Effects of Psilocybin.
Matthew W Johnson, Roland R Griffiths. Neurotherapeutics 2017
103
20

Homological scaffolds of brain functional networks.
G Petri, P Expert, F Turkheimer, R Carhart-Harris, D Nutt, P J Hellyer, F Vaccarino. J R Soc Interface 2014
158
20

Management of Treatment-Resistant Depression: Challenges and Strategies.
Daphne Voineskos, Zafiris J Daskalakis, Daniel M Blumberger. Neuropsychiatr Dis Treat 2020
79
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.